GIA
DGX icon

Gargoyle Investment Advisor’s Quest Diagnostics DGX Stock Holding History

Gargoyle Investment Advisor’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-13,820
Closed -$839K – 151
2014
Q3 		$839K Buy
13,820
+1,300
+10% +$80.1K 0.32% 81
2014
Q2 		$735K Buy
12,520
+3,650
+41% +$214K 0.28% 85
2014
Q1 		$514K Buy
+8,870
New +$475K 0.23% 98

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Gargoyle Investment Advisor's DGX Position: Q4 2014 in Review

Gargoyle Investment Advisor sold out of Quest Diagnostics (DGX) in Q4 2014, closing a stake of 13,820 shares — an estimated $839K sold.

Gargoyle Investment Advisor first reported a position in DGX in Q1 2014 and held it in 3 quarters. The position peaked at $839K in Q3 2014. 517 funds tracked by Wall St. Rank hold DGX as of Q4 2014.

  • Gargoyle Investment Advisor reported no remaining Quest Diagnostics position as of Q4 2014 after selling out during the quarter.
  • Gargoyle Investment Advisor sold 13,820 Quest Diagnostics shares in Q4 2014, an estimated $839K.
  • Gargoyle Investment Advisor first reported a position in Quest Diagnostics in Q1 2014 and held it in 3 quarters.
  • Gargoyle Investment Advisor's Quest Diagnostics position peaked at $839K in Q3 2014.
  • 517 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2014.

Based on Gargoyle Investment Advisor's 13F filing for Q4 2014, filed 11 Feb 2015.